aspirin and Cytokine Release Syndrome
aspirin has been researched along with Cytokine Release Syndrome in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "His course was complicated by cytokine storm and COVID-19-associated coagulopathy." | 1.56 | Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device. ( Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M, 2020) |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Tafazoli, A | 1 |
| Anil Kumar, S | 1 |
| Othman, M | 1 |
| Hodges, K | 1 |
| Mubashir, M | 1 |
| Insler, J | 1 |
| Estep, J | 1 |
| Hsich, E | 1 |
| Tong, M | 1 |
| Insler, S | 1 |
| Soltesz, E | 1 |
| Lee, WS | 1 |
| Margolskee, E | 1 |
| Macciò, A | 1 |
| Oppi, S | 1 |
| Madeddu, C | 1 |
Reviews
2 reviews available for aspirin and Cytokine Release Syndrome
| Article | Year |
|---|---|
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 | 2022 |
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
Topics: Adrenal Cortex Hormones; Aspirin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 | 2021 |
Other Studies
2 other studies available for aspirin and Cytokine Release Syndrome
| Article | Year |
|---|---|
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; | 2020 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Child; Clinical Laboratory Techniques; Coronavir | 2020 |